I don't have access to the who report but here is what I do have. RRM
Jefferies reiterated a Buy rating and boosted his price target on Unilife Corporation (NASDAQ: UNIS) to $9.00 (from $5.00) as discussions confirm validating nature of the recent Sanofi deal. Analyst Raj Denhoy commented, "Earlier this month, UNIS announced an agreement with Sanofi for wearable injectors where Sanofi will only buy such products for large volume drugs from UNIS for at least 15 years. The unprecedented nature of the deal was validated for us in comments by Sanofi at a recent industry conference."
UNS Price at posting:
67.0¢ Sentiment: Hold Disclosure: Held
